Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.
Financial Results:
Ajanta Pharma Ltd reported Revenues for Q2FY24 of ₹1,028.00 Crores up from ₹938.00 Crore year on year, a rise of 9.59%.
Total Expenses for Q2FY24 of ₹774.00 Crores down from ₹776.00 Crores year on year, a fall of 0.26%.
Consolidated Net Profit of ₹195.00 Crores up 24.2% from ₹157.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹15.24, up 24.71% from ₹12.22 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.